Photos: Jan Lipton


Prof. Thomas F. Lüscher

Professor Thomas Lüscher studied medicine at the University of Zurich, specialising in internal medicine and cardiology. He trained in cardiovascular research and echocardiography at the Mayo Clinic in Rochester, USA, later becoming Professor of Pharmacotherapy at the University of Basel.

Ruth Amstein, PhD

Dr. Ruth Amstein is Director of the Zurich Heart House since 2009. She joined the Foundation for Cardiovascular Research as Director Education in 1998. She graduated in Pharmacy from the Swiss Federal Institute of Technology (ETH) Zurich and achieved her Ph.D. degree at the University of Basel on pathophysiological processes in the cardiovascular system. Ten years working experience in the pharmaceutical industry with responsibilities in regulatory affairs, clinical research and marketing. In 1991 she was a co-founder of the European Course of Pharmaceutical Medicine at the University Hospital Basel where she acted as Programme Director until 1997. Clinic in Rochester, USA, later becoming Professor of Pharmacotherapy at the University of Basel.

Werner Schär

Werner Schär assumed the position of Chief Financial Officer for the Foundation for Cardiovascular Research on 1 July 2010. Following his commercial apprenticeship and further advanced studies, he graduated from AKAD, gaining the degree of Swiss federally certified expert for Accounting and Controlling. His career is distinguished by a 26-year tenure at a multinational concern in the textile industry.

Prof. John E. Deanfield

John Deanfield is British Heart Foundation Vandervell Professor of Cardiology at University College Hospital, London, UK. He is also Consultant Cardiologist at the Heart Hospital and Great Ormond Street Hospital, London. Professor Deanfield undertook his undergraduate training at Churchill College, Cambridge, UK and the Middlesex Hospital, London. He subsequently trained at the Hammersmith and Great Ormond Street Hospitals, London.

Professor Deanfield serves on many international advisory boards and is a member of the editorial boards of several major cardiovascular journals. He has published numerous articles in leading medical and scientific journals such as New England Journal of Medicine, Circulation and Heart. His principal research interest is vascular medicine, particularly the role of the endothelium in atherosclerosis.

Professor Deanfield has received numerous awards during his career, including the Churchill College Anatomy Award (1970) and the Outstanding Research Award in Paediatric Cardiology (American Heart Association, 2003).

Johannes Holzmeister, MD

Dr. Holzmeister is an internationally recognized cardiologist and has nearly two decades of clinical research experience. Prior to co-founding Cardiorentis in 2010, he worked at the University Hospital of Zürich where he led the interventional device group for heart failure patients. Dr. Holzmeister’s research has been published in leading medical journals including The New England Journal of Medicine and The Lancet. He is a board-certified cardiologist and received his M.D. from Humboldt University of Berlin.